跳至主要内容
临床试验/JPRN-UMIN000009839
JPRN-UMIN000009839已完成未知

Cytapheresis (Leukocyte Apheresis) for remission maintenance therapy of ulcerative colitis: multicenter randomized controlled study. - CAPTAIN study

Division of Gastroenterology Department of Internal Medicine, Keio university hospital0 个研究点目标入组 164 人开始时间: 2013年1月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
164

研究概览

简要总结

The cumulative remission rate at 12 months was 46.6% in the apheresis group and 36.4% in the control group (p=0.1621). The rate of endoscopic remission at 12 months was significantly higher in the apheresis group than in the control group (42.5% vs. 25.9%) p=0.0480). No severe adverse events were observed in either group.

研究设计

研究类型
Interventional

入排标准

年龄范围
12years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who are contraindicated use of Adacolumn or Cellsorba E.

研究者

发起方
Division of Gastroenterology Department of Internal Medicine, Keio university hospital

相似试验